Organoids are valuable tools to study cancer, identify and target novel therapies, and facilitate translational cancer research. These 3-D models are becoming more relevant because they are predictive of the in vivo tumor microenvironment. In efforts to simplify Organoid culture, ATCC has developed Organoid Growth Kits which comprise single-use supplements created to streamline media preparation. These kits contain the most costly and cumbersome supplements and reagents, reducing the time and effort required to prepare media and ensuring the successful growth of your organoids.
Watch our tutorial on creating complete media using ATCC Organoid Growth Kits
** Organoid technology is subject to various patent rights; please consult your patent counsel regarding the need for licenses, including without limitation for uses beyond the scope permitted by the HUB Addendum to the ATCC MTA.
Advanced cell models
ATCC provides organoids isolated from multiple organs including colon, small intestine, stomach, breast, esophagus, lung, liver, prostate, and pancreas. Discover their advantages over existing cancer models.
HCMI Cancer Models
We are continually adding 2-D and 3-D patient-derived cancer models to our portfolio. These next-generation models include both common as well as rare and understudied examples of cancer from numerous tissues.